Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2018C045 Product name: daunorubicine/cytarabine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2018C/045
Type:
Certificate
SPC type:
Medical
Basic patent number:
057388852
Status:
Active
Publication number:
2018C045
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/18/1308
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
24/08/2018
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
30/11/2018
First marketing authorization date:
24/08/2018
Grant date:
08/08/2024
Activation date:
22/04/2025
BE Publication date:
06/12/2018
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
22/04/2030
SPC/SPC Extension Expiration (if granted and all annual fees paid):
22/04/2030
Rejection date:
Withdrawal date:

Applicant

Name:
Celator Pharmaceuticals, Inc.
Legal Form:
From:
30/11/2018
Address:
200 PrincetonSouth Corporate Center Suite 180, Ewing, NJ 08628, United States (US)
To:

Agent

Name:
JAEKEN Annemie
Legal Form:
From:
06/12/2018
Address:
Gaston Geenslaan 11, 3001, HEVERLEE, Belgium (BE)
To:

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2018/34
Publication date:
16/01/2019
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
SPC
Journal edition number:
2024/15
Publication date:
29/08/2024
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

3

Bulletin heading:
SPC
Journal edition number:
2025/08
Publication date:
03/07/2025
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

Annual fee

Annual fee(s) Due Date:
30/04/2027
Annual fee number:
23
Annual fee amount:
750 Euro
Expected payer:
Last annual fee payment date:
17/03/2026
Last annual fee paid number:
22
Last annual fee paid amount:
700 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
30/11/2018 General Document Other 1 PDF /3/8/5/6/9/0721796583/docs/2018c045_0_generaldocument_20181206_104249555.pdf
30/11/2018 General Document Other 52 PDF /3/8/5/6/9/0721796583/docs/2018c045_1_generaldocument_20181206_104249624.pdf
30/11/2018 Abstract Product Characteristics Abstract of the characteristics of the product 29 PDF /3/8/5/6/9/0721796583/docs/2018c045_2_abstractproductcharacteristics_20181206_104249397.pdf
06/12/2018 Outgoing Correspondence 2 PDF /3/8/5/6/9/0721796583/docs/2018c045_3_outgoingcorrespondence_20181210_101846830.pdf
30/11/2018 Application Form 3 PDF /3/8/5/6/9/0721796583/docs/2018c045_4_applicationform_20181206_104249323.pdf
30/11/2018 Request For Change Letter and/or Form requesting a change in the Register 6 PDF /3/8/5/6/9/0721796583/docs/2018c045_5_rfc_20181212_043243998.pdf
06/12/2018 Front Page 1 PDF /3/8/5/6/9/0721796583/docs/2018c045_6_i1frontpage_20181206_134753578.pdf
06/12/2018 Publication I1 1 PDF /3/8/5/6/9/0721796583/docs/2018c045_7_i1document_20181206_134754549.pdf
30/11/2018 Application Form Copy of a previously filed patent application referred to 3 PDF /3/8/5/6/9/0721796583/docs/2018c045_8_applicationform_20181210_012929926.pdf
08/08/2024 Publication I2 1 PDF /3/8/5/6/9/0721796583/docs/2018c045_9_i2document_20240808_112508664.pdf
08/08/2024 Outgoing Correspondence 2 PDF /3/8/5/6/9/0721796583/docs/2018c045_10_outgoingcorrespondence_20240902_121201480.pdf
30/11/2018 Marketing Authorization 1st Marketing Authorization (EU) 4 PDF /3/8/5/6/9/0721796583/docs/2018c045_11_marketingauthorization_20181206_104249478.pdf